Insider Transactions in Q2 2025 at Aclaris Therapeutics, Inc. (ACRS)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2025
|
Christopher P. Molineaux |
BUY
Exercise of conversion of derivative security
|
Direct |
4,793
+7.64%
|
-
|
|
Jun 06
2025
|
Maxine Gowen |
BUY
Exercise of conversion of derivative security
|
Direct |
4,793
+18.05%
|
-
|
|
Jun 06
2025
|
William D. Humphries |
BUY
Exercise of conversion of derivative security
|
Direct |
4,793
+12.51%
|
-
|
|
Jun 06
2025
|
Anand Mehra |
BUY
Exercise of conversion of derivative security
|
Direct |
4,793
+0.67%
|
-
|
|
Jun 06
2025
|
Vincent Milano |
BUY
Exercise of conversion of derivative security
|
Direct |
4,793
+21.68%
|
-
|
|
Jun 06
2025
|
Andrew N Schiff |
BUY
Exercise of conversion of derivative security
|
Direct |
4,793
+25.56%
|
-
|
|
May 01
2025
|
Neal Walker CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,975
-0.2%
|
$2,975
$1.38 P/Share
|
|
May 01
2025
|
Neal Walker CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,467
+0.63%
|
-
|
|
Apr 01
2025
|
Neal Walker CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,042
-0.21%
|
$3,042
$1.48 P/Share
|
|
Apr 01
2025
|
Neal Walker CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,467
+0.64%
|
-
|